×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PCVX – vaxcyte, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PCVX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
07:11 am
pcvx
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study [Yahoo! Finance]
Low
Report
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study [Yahoo! Finance]
3/31
07:00 am
pcvx
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
High
Report
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
3/30
05:00 pm
pcvx
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
High
Report
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
3/25
08:27 am
pcvx
Vaxcyte (PCVX) Struggled Amid Political Uncertainty [Yahoo! Finance]
Low
Report
Vaxcyte (PCVX) Struggled Amid Political Uncertainty [Yahoo! Finance]
3/14
08:16 pm
pcvx
Market Correction: This Dirt Cheap ETF Is Down by Almost 20% [Yahoo! Finance]
Low
Report
Market Correction: This Dirt Cheap ETF Is Down by Almost 20% [Yahoo! Finance]
3/12
10:12 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
Low
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
2/26
11:36 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
Medium
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $160.00 price target on the stock.
2/26
08:00 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $140.00 price target on the stock.
Low
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $140.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/31
08:36 am
pcvx
Form 8-K Vaxcyte, Inc. For: Mar 31
High
Report
Form 8-K Vaxcyte, Inc. For: Mar 31
3/7
04:43 pm
pcvx
Form 4 Vaxcyte, Inc. For: Mar 05 Filed by: Eydelman Mikhail
Medium
Report
Form 4 Vaxcyte, Inc. For: Mar 05 Filed by: Eydelman Mikhail
3/5
04:11 pm
pcvx
Form 144 Vaxcyte, Inc. Filed by: Eydelman Mikhail
Low
Report
Form 144 Vaxcyte, Inc. Filed by: Eydelman Mikhail
3/3
09:32 pm
pcvx
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: GUGGENHIME ANDREW
Low
Report
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: GUGGENHIME ANDREW
3/3
09:16 pm
pcvx
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: Cowan Elvia
Low
Report
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: Cowan Elvia
3/3
09:15 pm
pcvx
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: Eydelman Mikhail
Low
Report
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: Eydelman Mikhail
3/3
09:14 pm
pcvx
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: Wassil Jim
Low
Report
Form 4 Vaxcyte, Inc. For: Feb 27 Filed by: Wassil Jim
3/3
09:13 pm
pcvx
Form 4 Vaxcyte, Inc. For: Dec 31 Filed by: Wassil Jim
Low
Report
Form 4 Vaxcyte, Inc. For: Dec 31 Filed by: Wassil Jim
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: